Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation.
Reads0
Chats0
TLDR
Despite limitations in scope and generalizability, human IV endotoxin challenge offers a unique platform to gain mechanistic insights into inducible physiological responses and inflammatory pathways, and may aid translation of this knowledge into therapeutic innovations.Abstract:
Activation of inflammatory pathways represents a central mechanism in multiple disease states both acute and chronic. Triggered via either pathogen or tissue damage-associated molecular motifs, common biochemical pathways lead to conserved yet variable physiological and immunological alterations. Dissection and delineation of the determinants and mechanisms underlying phenotypic variance in response is expected to yield novel therapeutic advances. Intravenous (IV) administration of endotoxin (gram-negative bacterial lipopolysaccharide), a specific Toll-like receptor 4 agonist, represents an in vivo model of systemic inflammation in man. National Institutes for Health Clinical Center Reference Endotoxin (CCRE, Escherichia coli O:113:H10:K negative) is employed to reliably and reproducibly generate vascular, hematological, endocrine, immunological and organ-specific functional effects that parallel, to varying degrees, those seen in the early stages of pathological states. Alteration of dose (0.06 - 4 ng/kg) and time-scale of exposure (bolus vs. infusion) allows replication of either acute or chronic inflammation and a range of severity to be elicited, with higher doses (2 - 4 ng/kg) frequently being used to create a 'sepsis-like' state. Established and novel medicinal compounds may additionally be administered prior to or post endotoxin exposure to appreciate their effect on the inflammatory cascade. Despite limitations in scope and generalizability, human IV endotoxin challenge offers a unique platform to gain mechanistic insights into inducible physiological responses and inflammatory pathways. Rationally employed it may aid translation of this knowledge into therapeutic innovations.read more
Citations
More filters
Journal ArticleDOI
The fate and lifespan of human monocyte subsets in steady state and systemic inflammation.
Amit Patel,Yan Zhang,James N. Fullerton,Lies Boelen,Anthony Rongvaux,Alexander A. Maini,Bigley,Richard A. Flavell,Richard A. Flavell,Derek W. Gilroy,Becca Asquith,Derek C. Macallan,Derek C. Macallan,Simon Yona +13 more
TL;DR: It is demonstrated that classical monocytes emerge first from marrow, after a postmitotic interval of 1.6 d, and circulate for a day, which is consistent with a model of sequential transition.
Journal ArticleDOI
The “Leaky Gut”: Tight Junctions but Loose Associations?
TL;DR: Data is reviewed to provide data that will support the conclusion that the intestinal paracellular space is a major route of transport of water and small solutes such as ions and small soluble organic molecules between the lumen and submucosal space, and not a means by which large molecules, lipophilic substances, or macromolecular structures such as proteins, particulate matter, or intact bacteria are absorbed.
Journal ArticleDOI
Two Distinct Immune Pathways Linking Social Relationships With Health: Inflammatory and Antiviral Processes.
TL;DR: It is suggested that adverse social experiences (social isolation, perceived social threat) may induce inflammatory responses while suppressing antiviral immunity, whereas positive experiences of social connection may reduce inflammation and bolster antiviral responses.
Journal ArticleDOI
Monocytes, macrophages, dendritic cells and neutrophils: an update on lifespan kinetics in health and disease
TL;DR: In this paper, the kinetic profiles of innate myeloid cells during steady state and pathology are analyzed to support the rational development of therapies to boost the production of these cells in times of need or reduce them when detrimental.
Journal ArticleDOI
Sepsis-induced multi-organ dysfunction syndrome—a mechanistic approach
TL;DR: From a holistic viewpoint, all proposed pathways leading to sepsis-induced MODS probably are closely intertwined which renders a single therapeutic approach for sepsi-inducedMODS irrelevant.
References
More filters
Journal ArticleDOI
Circulating mitochondrial DAMPs cause inflammatory responses to injury
Qin Zhang,Mustafa Raoof,Yu Chen,Yuka Sumi,Tolga Sursal,Wolfgang G. Junger,Karim Brohi,Kiyoshi Itagaki,Carl J. Hauser +8 more
TL;DR: It is shown that injury releases mitochondrial DAMPs into the circulation with functionally important immune consequences, including formyl peptides and mitochondrial DNA, which promote PMN Ca2+ flux and phosphorylation of mitogen-activated protein (MAP) kinases, thus leading to PMN migration and degranulation in vitro and in vivo.
Journal ArticleDOI
Genomic responses in mouse models poorly mimic human inflammatory diseases
Seok Junhee Seok,Shaw Warren,G. Cuenca Alex,N. Mindrinos Michael,V. Baker Henry,Weihong Xu,Daniel R. Richards,Grace P. McDonald-Smith,Hong Gao,Laura Hennessy,Celeste C. Finnerty,Cecilia M Lopez,Shari Honari,Ernest E. Moore,Joseph P. Minei,Joseph Cuschieri,Paul E. Bankey,Jeffrey L. Johnson,Jason L. Sperry,Avery B. Nathens,Timothy R. Billiar,Michael West,Marc G. Jeschke,Matthew B. Klein,Richard L. Gamelli,Nicole S. Gibran,Bernard H. Brownstein,Carol L. Miller-Graziano,Steve E. Calvano,Philip H. Mason,J. Perren Cobb,Laurence G. Rahme,Stephen F. Lowry,Ronald V. Maier,Lyle L. Moldawer,David N. Herndon,Ronald W. Davis,Wenzhong Xiao,Wenzhong Xiao,Ronald G. Tompkins +39 more
TL;DR: This study shows that, although acute inflammatory stresses from different etiologies result in highly similar genomic responses in humans, the responses in corresponding mouse models correlate poorly with the human conditions and also, one another.
Journal ArticleDOI
Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors.
Hans Brightbill,Daniel H. Libraty,Stephan R. Krutzik,Ruey-Bing Yang,John T. Belisle,Joshua R. Bleharski,Michael Maitland,Michael V. Norgard,Scott E. Plevy,Stephen T. Smale,Patrick J. Brennan,Barry R. Bloom,Barry R. Bloom,Paul J. Godowski,Robert L. Modlin +14 more
TL;DR: It is shown that microbial lipoproteins are potent stimulators of IL-12 production by human macrophages, and that induction is mediated by Toll-like receptors (TLRs), and that Activation of TLRs by microbes may initiate innate defense mechanisms against infectious pathogens.
Journal ArticleDOI
Extracellular histones are major mediators of death in sepsis
Jun Xu,Xiaomei Zhang,Rosana Pelayo,Marc Monestier,Concetta T. Ammollo,Fabrizio Semeraro,Fletcher B. Taylor,Naomi L. Esmon,Florea Lupu,Charles T. Esmon,Charles T. Esmon +10 more
TL;DR: It is concluded that extracellular histones are potential molecular targets for therapeutics for sepsis and other inflammatory diseases.
Journal ArticleDOI
Can Animal Models of Disease Reliably Inform Human Studies
H. Bart van der Worp,David W. Howells,Emily S. Sena,Emily S. Sena,Michelle J. Porritt,Sarah S J Rewell,Victoria E O'Collins,Malcolm R. Macleod +7 more
TL;DR: H. Bart van der Worp and colleagues discuss the controversies and possibilities of translating the results of animal experiments into human clinical trials and the prospects of doing so in the coming years.
Related Papers (5)
Toll-like receptor (TLR) response tolerance: a key physiological "damage limitation" effect and an important potential opportunity for therapy.
Molecular Mechanisms and Pathological Consequences of Endotoxin Tolerance and Priming
Matthew C. Morris,Liwu Li +1 more